- Filed
- Nov 19, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 19, 2025 | 31.4M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 31.44M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 20.07M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 9.8M sh |
| Shares Diluted restated | Q3 2025 · Sep 30, 2024 | 9.72M sh |
| Capex | Q3 2025 · Sep 30, 2025 | $2K |
| Capex restated | Q3 2025 · Sep 30, 2024 | $13K |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | −$7.04M |
| Operating Cash Flow restated | Q3 2025 · Sep 30, 2024 | −$2.24M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $131.44M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $0 |
| Short Term Debt | Q3 2025 · Sep 30, 2025 | $267K |
| Short Term Investments | Q3 2025 · Sep 30, 2025 | $1.38M |
| Short Term Investments | Q3 2025 · Dec 31, 2024 | $340K |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $243.8M |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $79.61M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $2.85M |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $3.5M |
| Stockholders Equity restated | Q3 2025 · Sep 30, 2024 | $3.96M |
| Stockholders Equity restated | Q3 2025 · Jun 30, 2024 | $4.26M |
| Stockholders Equity restated | Q3 2025 · Mar 31, 2024 | $4.96M |
| Stockholders Equity restated | Q3 2025 · Dec 31, 2023 | $5.82M |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $85.55M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $593K |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $236.15M |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $874K |
| Current Assets | Q3 2025 · Sep 30, 2025 | $174.41M |
| Current Assets | Q3 2025 · Dec 31, 2024 | $3.28M |
| Total Assets | Q3 2025 · Sep 30, 2025 | $479.95M |
| Total Assets | Q3 2025 · Dec 31, 2024 | $4.38M |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $1.83 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $3.63 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.05 |
| Eps Diluted restated | Q3 2025 · Sep 30, 2024 | −$0.23 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $2.41 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $4.47 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.05 |
| Eps Basic restated | Q3 2025 · Sep 30, 2024 | −$0.23 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $3.57M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $8.79M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $564K |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $1.99M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $269K |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $751K |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $151K |
| Rd Expense restated | Q3 2025 · Sep 30, 2024 | $479K |
| Net Income | Q3 2025 · Sep 30, 2025 | $56.03M |
| Net Income | Q3 2025 · Sep 30, 2025 | $70.68M |
| Net Income | Q3 2025 · Jun 30, 2025 | $15.43M |
| Net Income | Q3 2025 · Mar 31, 2025 | −$778K |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$471K |
| Net Income restated | Q3 2025 · Sep 30, 2024 | −$2.24M |
| Net Income restated | Q3 2025 · Jun 30, 2024 | −$805K |
| Net Income restated | Q3 2025 · Mar 31, 2024 | −$964K |
| Operating Income | Q3 2025 · Sep 30, 2025 | $72.09M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $88.39M |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$454K |
| Operating Income restated | Q3 2025 · Sep 30, 2024 | −$2.32M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $88K |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $122K |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $8K |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $24K |
| Revenue | Q3 2025 · Sep 30, 2025 | $4.63M |
| Revenue | Q3 2025 · Sep 30, 2025 | $6.9M |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $619K |
| Revenue restated | Q3 2025 · Sep 30, 2024 | $1.47M |
| Stock Repurchased restated | Q3 2025 · Sep 30, 2024 | $5K |